Does APIXABAN Cause Potentiating drug interaction? 28 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 28 reports of Potentiating drug interaction have been filed in association with APIXABAN (ELIQUIS). This represents 0.0% of all adverse event reports for APIXABAN.
28
Reports of Potentiating drug interaction with APIXABAN
0.0%
of all APIXABAN reports
2
Deaths
21
Hospitalizations
How Dangerous Is Potentiating drug interaction From APIXABAN?
Of the 28 reports, 2 (7.1%) resulted in death, 21 (75.0%) required hospitalization.
Is Potentiating drug interaction Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for APIXABAN. However, 28 reports have been filed with the FAERS database.
What Other Side Effects Does APIXABAN Cause?
Death (18,501)
Cerebrovascular accident (7,237)
Atrial fibrillation (5,690)
Off label use (5,590)
Thrombosis (5,298)
Fall (5,063)
Cardiac disorder (4,917)
Haemorrhage (4,770)
Dyspnoea (4,379)
Gastrointestinal haemorrhage (4,030)
What Other Drugs Cause Potentiating drug interaction?
METFORMIN (150)
METHOTREXATE (119)
QUETIAPINE (98)
ASPIRIN (87)
RIVAROXABAN (71)
PREGABALIN (67)
TACROLIMUS (56)
AMIODARONE (53)
CLARITHROMYCIN (52)
GABAPENTIN (52)
Which APIXABAN Alternatives Have Lower Potentiating drug interaction Risk?
APIXABAN vs APOMORPHINE
APIXABAN vs APRACLONIDINE
APIXABAN vs APREMILAST
APIXABAN vs APREPITANT
APIXABAN vs APROTININ